# Aveanna Healthcare Holdings Inc. (AVAH) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $13.58, market value $3.0 billion.

## Valuation
- **P/E (trailing): 10.8×** (5-yr avg 7.7×, 3-yr avg 7.7×). Aveanna Healthcare Holdings Inc. trades at 10.8× trailing earnings, well above its own five-year average of 7.7×: investors are paying up relative to the company's past. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 15.1×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.01**. A PEG of 0.01 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.1×**. Each dollar of revenue is priced at 1.1×.
- **Price / book: 10.3×**. The shares trade at 10.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 14.3×**. Enterprise value is 14.3× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Earnings yield: 9.3%**. The inverse of the P/E: 9.3% of the price is earned each year.

## Profitability
- **Gross margin: 32.3%**. Aveanna Healthcare Holdings Inc. keeps 32.3% of revenue after the direct cost of what it sells.
- **Operating margin: 10.5%**. 10.5% of revenue is left after running the business.
- **Net margin: 9.2%**. 9.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 115.7%**. A 115.7% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 16.6%**. Return on all capital, debt included, is 16.6%: comfortably above what that capital costs.
- **Return on assets: 13.7%**. Each dollar of assets produces 13.7% of profit.

## Growth
- **Revenue growth (1 yr): 20.2%** (3-yr 10.8%/yr, 5-yr 10.2%/yr). Revenue grew 20.2% over the last year, against 10.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 1850.0%**. Earnings per share rose 1850.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 6.68**. Debt is 6.68 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 3.9×**. It would take 3.9 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 2.74**. A Z-score of 2.74 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Aveanna Healthcare Holdings Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (10 analysts). 10 analysts cover Aveanna Healthcare Holdings Inc.; the consensus is buy, with an average price target of $13.35 (-2% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 68.1%** (YTD 66.2%, 3-mo 103.3%). The shares are up 68.1% over twelve months including dividends.
- **From 52-week high: -3.0%** (129.0% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 70**. An RSI of 70 is neutral.
- **Beta (1 yr): 0.80** (volatility 50%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AVAH · Page: https://foliofundamentals.com/stocks/avah

Not investment advice.